Article

Intra-Individual Variability of Lipoprotein(a) After Acute Coronary Syndrome: A Long-Term Cohort Study

2026-02-14

Abstract excerpt

<h4>Background: </h4> Lipoprotein(a) [Lp(a)] is a casual and independent risk factor for atherosclerotic cardiovascular disease (ASCVD) and is largely genetically determined. However, recent studies indicate significant intra-individual variability, particularly among patients with intermediate Lp(a) levels (30–50 mg/dL). Yet, data on long-term variability are limited, and acute coronary syndrome (ACS) may further...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 61e8ea57-b50b-53f1-885e-6b20d10deb4d
DOI: 10.20944/preprints202602.1186.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Intra-Individual Variability of Lipoprotein(a) After Acute Coronary Syndrome: A Long-Term Cohort StudyDOI 10.20944/preprints202602.1186.v1Read

Impact of Lipoprotein (a) on Residual Cardiovascular Risk after an Acute Coronary SyndromeSemantic proximity Read

Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association.Semantic proximity Read

Longitudinal Variability of Lipoprotein(a) in Children with Type 1 Diabetes: Implications for Cardiovascular Risk StratificationSemantic proximity Read

Lipoprotein(a) and Traditional Risk Factors as Predictors of Premature Coronary Artery Disease: A Single-Center Retrospective StudySemantic proximity Read

Phenotypic Clustering Identifies Heterogeneous Cardiovascular Risk Among Patients with Elevated Lipoprotein(a)Semantic proximity Read

Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Where Do We Stand?Semantic proximity Read

Impact of elevated lipoprotein(a) on coronary artery disease phenotype and severity.Semantic proximity Read

Phenotypic clustering identifies heterogeneous cardiovascular risk among patients with elevated lipoprotein(a).Semantic proximity Read

Lipoprotein(a) metabolomic and proteomic features and atherosclerotic cardiovascular disease in young, healthy adultsSemantic proximity Read

Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease: Prospective 5 Years of Follow-Up and Apolipoprotein(a) Characterization.Semantic proximity Read

[Lipoprotein (a): variability and association with coronary disease].Semantic proximity Read

Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases – Some answers and still many questionsSemantic proximity Read